REQUEST A DEMO
Total
USD $0.00
Search more companies

Resbiomed OOD (Bulgaria)

Main Activities: Research and Development in Nanotechnology
Full name: Resbiomed OOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Resbiomed OOD is a company based in Bulgaria, with its head office in Sofia. It operates in the Research and Development in Nanotechnology industry. It was first established on February 25, 2002. 15 (2023) employees currently work for Resbiomed OOD. In 2022, the company reported a net sales revenue increase of 33.52%. Its’ total assets recorded a growth of 9.21%. In, 2022, the company’s net profit margin decreased by 12.6%.

Headquarters
144 Aldomirovska Str.
Sofia; Sofia - city; Postal Code: 1309

Contact Details: Purchase the Resbiomed OOD report to view the information.

Basic Information
Total Employees:
Purchase the Resbiomed OOD report to view the information.
Outstanding Shares:
Purchase the Resbiomed OOD report to view the information.
Registered Capital:
Purchase the Resbiomed OOD report to view the information.
Incorporation Date:
February 25, 2002
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
49%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Resbiomed OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
33.52%
Total operating revenue
33.2%
Net Profit (Loss) for the Period
8.24%
Total assets
9.21%
Total equity
9.16%
Net Profit Margin
-12.6%
Return on Equity (ROE)
-0.14%
Quick Ratio
1.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?